What is Nanosphere Health Sciences Inc?
, a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada.
NSHSF · Verdict
Solid reward · elevated risk
NSHSF stands out on growth and volatility, but watch the cash flow signal.
Based on 88% data coverage
NSHSF · Verdict
Top decile vs peers
Above average
Weak vs peers
0% return on equity
Model-based scoring. For information only — not financial advice.
, a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, animal health, and other industries. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 446.65K, and a P/E ratio of 0.3x.
The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.